Tourette Syndrome clinical trials
15 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
- Trajectories of Change in Tourette Syndrome
- Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder
- Neurofeedback From the Supplementary Motor Area for Tourette Syndrome
- Remote Delivery of a Mindfulness-based Intervention for Tics
- Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
- Longitudinal Impact of Stressors in Adults With Tourette Syndrome
- Sensory Symptoms in Tourette Syndrome
- A Multicenter Pediatric Deep Brain Stimulation Registry
- Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
- CBIT+TMS R33 Phase
- Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics
- SCI-110 in the Treatment of Tourette Syndrome
- Neural Correlates of Sensory Phenomena in Tourette Syndrome
- Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Tourette Syndrome” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.